Insilico teams up with US firm to build AI models predicting disease decades ahead
Insilico Medicine and Human Longevity have formed a partnership to develop AI models capable of predicting diseases decades in advance. This collaboration aims to advance personalized health research by integrating Insilico's AI algorithms with Human Longevity's extensive genomic data. The venture, described as a multimillion-dollar co-development effort, is expected to accelerate the discovery of new longevity drugs. AI
IMPACT This collaboration could accelerate the discovery of new longevity drugs and advance personalized health research.